Total submissions: 18
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000229666 | SCV000288623 | benign | Fanconi anemia | 2024-02-01 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000317116 | SCV000484369 | likely benign | Inclusion Body Myopathy, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV000353275 | SCV000484370 | likely benign | Amyotrophic Lateral Sclerosis, Dominant | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000121035 | SCV000594705 | benign | not specified | 2016-11-14 | criteria provided, single submitter | clinical testing | |
Illumina Laboratory Services, |
RCV001168311 | SCV001330891 | uncertain significance | Fanconi anemia complementation group G | 2017-04-27 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Genome- |
RCV001168311 | SCV001653325 | likely benign | Fanconi anemia complementation group G | 2021-05-18 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001194965 | SCV001834775 | likely benign | not provided | 2020-10-08 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26033879, 12552564, 16643430) |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000121035 | SCV003844910 | benign | not specified | 2023-02-17 | criteria provided, single submitter | clinical testing | Variant summary: FANCG c.1538G>A (p.Arg513Gln) results in a conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0083 in 251472 control chromosomes in the gnomAD database, including 14 homozygotes. The observed variant frequency is approximately 9.41 fold of the estimated maximal expected allele frequency for a pathogenic variant in FANCG causing Fanconi Anemia phenotype (0.00088), strongly suggesting that the variant is benign. c.1538G>A has been reported in the literature in individuals affected with Fanconi Anemia and Acute Myeloid Leukemia (e.g., Meyer_2006, Nicchia_2015) however without strong evidence for causality. These reports therefore do not provide conclusions about association of the variant with Fanconi Anemia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Eight ClinVar submitters (evaluation after 2014) have reported the variant with conflicting assessments: three cite the variant as benign, three cite the variant as likely benign, one cites the variant as uncertain signficance, and one cites the variant as pathogenic. Based on the evidence outlined above, the variant was classified as benign. |
KCCC/NGS Laboratory, |
RCV001168311 | SCV004017686 | benign | Fanconi anemia complementation group G | 2023-07-07 | criteria provided, single submitter | clinical testing | |
Ce |
RCV001194965 | SCV004157696 | benign | not provided | 2024-08-01 | criteria provided, single submitter | clinical testing | FANCG: BP4, BS1, BS2 |
Molecular Genetics, |
RCV001168311 | SCV004812750 | benign | Fanconi anemia complementation group G | 2024-01-05 | criteria provided, single submitter | clinical testing | |
ITMI | RCV000121035 | SCV000085203 | not provided | not specified | 2013-09-19 | no assertion provided | reference population | |
Prevention |
RCV003891643 | SCV000310551 | benign | FANCG-related disorder | 2019-10-09 | no assertion criteria provided | clinical testing | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Leiden Open Variation Database | RCV001194965 | SCV001364839 | pathogenic | not provided | 2020-02-28 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Johan de Winter. |
Natera, |
RCV001168311 | SCV001452297 | benign | Fanconi anemia complementation group G | 2020-09-16 | no assertion criteria provided | clinical testing | |
Genome Diagnostics Laboratory, |
RCV000121035 | SCV001809787 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000121035 | SCV001931526 | benign | not specified | no assertion criteria provided | clinical testing | ||
Laboratory of Diagnostic Genome Analysis, |
RCV001194965 | SCV002036805 | likely benign | not provided | no assertion criteria provided | clinical testing |